Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Walter Bau-AG ST

Start price
Target price
Perf. (%)
€0.001
11.09.20
€0.002
24.09.20
300.00%
24.09.20

Undervalued
Risky Investment
High risks for its business
No Innovation
Kelly Services Inc. A

Start price
Target price
Perf. (%)
€14.30
10.09.20
-
15.09.20
-2.10%
15.09.20

Risky Investment
Geely Automobile Holdings

Start price
Target price
Perf. (%)
€1.72
10.09.20
-
04.11.21
32.36%
16.11.20

Some uniques
Below average Management
Business model of the past or high risk
buy
Satsuma Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.60
10.09.20
-
19.09.20
-32.50%
19.09.20

Good culture
Could be very worthwhile Investment >20% year
Capable Management
Few uniques
News Corp. B

Start price
Target price
Perf. (%)
€12.60
10.09.20
-
04.11.21
18.25%
20.11.20

Low dividend yield expected
Revenue decline/stagnation expected
negative Cash Flow expected
Few uniques
Reconnaissance Energy Afri.ltd

Start price
Target price
Perf. (%)
€0.72
10.09.20
-
04.11.21
477.08%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Quantafuel ASA

Start price
Target price
Perf. (%)
€8.14
10.09.20
-
04.11.21
-69.26%
05.11.21

Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Lower EBIT Margin than peer group
High valuation
buy
Amira Nature Food Ltd.

Start price
Target price
Perf. (%)
€1.58
10.09.20
-
04.11.21
463.29%
05.11.21

Fair valuation
Low dividend yield expected
negative Cash Flow expected
Bad rating
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€48.40
10.09.20
-
04.11.21
-26.12%
05.11.21

Revenue growth >5% per year expected
Higher EBIT margin than peer group
positive Cash Flow expected
Increased challenges to pay loans and raise capital
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€52.11
09.09.20
€85.00
19.10.20
58.30%
19.10.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Very Future proof/growth oriented business model
Capable Management
buy
Urban One Inc.

Start price
Target price
Perf. (%)
€3.08
09.09.20
-
19.09.20
5.84%
19.09.20

EBIT decline > 20% expected
very negative Cash Flow expected
Junk rating
High challenges to pay loans and raise capital
buy
Vaxart Inc.

Start price
Target price
Perf. (%)
€4.22
09.09.20
€8.00
04.11.21
42.75%
05.11.21

Could be worthwhile Investment >10% per year
buy
Eastman Kodak

Start price
Target price
Perf. (%)
€5.08
09.09.20
€13.00
19.09.20
94.49%
19.09.20

Could be worthwhile Investment >10% per year
Below average Marketposition
Very high cyclical dependencies
Little known brand
Tesla Inc

Start price
Target price
Perf. (%)
€99.58
09.09.20
-
01.10.20
27.08%
01.10.20

buy
Panasonic Corp.

Start price
Target price
Perf. (%)
€7.65
09.09.20
-
04.11.21
14.30%
11.11.20

Some uniques
Future proof or reliable business model
Innovative
Differentiated customer and product portfolio
buy
Commerce Resources Corp.

Start price
Target price
Perf. (%)
€0.026
09.09.20
€0.000
04.11.21
-
08.03.21

Moderna Inc.

Start price
Target price
Perf. (%)
€48.88
08.09.20
-
04.11.21
36.01%
11.11.20

Significant cyclical dependencies
Higher risks for its business
buy
Corbus Pharmaceuticals Holding Inc.

Start price
Target price
Perf. (%)
€47.63
08.09.20
-
19.09.20
-4.25%
19.09.20

Could be worthwhile Investment >10% per year
Very bad culture
No uniques
Below average Management
buy
Premier Foods plc

Start price
Target price
Perf. (%)
€0.86
08.09.20
€1.00
04.11.21
45.88%
05.11.21

Could be very worthwhile Investment >20% year
Strong uniques
buy
Hexo Corp.

Start price
Target price
Perf. (%)
€31.77
08.09.20
€56.00
04.11.21
-45.36%
05.11.21

Could be worthwhile Investment >10% per year
Fair valuation
Top 10 in its market
buy
Altimmune

Start price
Target price
Perf. (%)
€10.11
08.09.20
€12.00
04.11.21
-8.42%
05.11.21

Could be worthwhile Investment >10% per year
Fair valuation
buy
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.60
08.09.20
€7.00
21.09.20
46.07%
21.09.20

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
Leading role in innovation
buy
Co-diagnostics Inc.

Start price
Target price
Perf. (%)
€7.00
08.09.20
€8.00
04.11.21
2.57%
05.11.21

Could be worthwhile Investment >10% per year
Very differentiated customer and product portfolio
buy
JinkoSolar Holding Co. Ltd. ADR

Start price
Target price
Perf. (%)
€17.58
08.09.20
-
04.11.21
221.96%
26.11.20

Sustainability is very important
Innovative
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€135.80
08.09.20
€175.00
16.10.20
20.03%
16.10.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
positive Cash Flow expected